Day: April 6, 2022
Company announcement no. 03/2022
April 6, 2022
Strong Q2 growth in a challenging environment
Statement by CEO Mauricio Graber: “In a challenging environment, Chr. Hansen continued its strong growth trajectory, delivering 14% organic growth in the second quarter. Growth in Health & Nutrition further accelerated, supported by Human Health, while Food Cultures & Enzymes showed solid growth, mainly driven by its core segments and developed markets. In the second quarter, the EBIT margin b.s.i. increased to 27.7% thanks to strong volume growth. The performance in the first half of the year provides a robust foundation for delivering on our ambitions for the full year. However, overall market volatility has increased due to the accelerating inflationary pressure and the Russian invasion of Ukraine. We are responding to the higher cost...
Proactive news headlines including PVW Resources, Emperor Energy, GTI Resources and Meeka Gold
Written by Customer Service on . Posted in Mergers And Acquisitions.
Sydney, April 06, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:PVW Resources NL (ASX:PVW) has secured commitments from existing and new institutional and high net-worth investors to raise $9.5 million in a heavily oversubscribed placement to advance its Tanami REE Project in the Kimberley region of Western Australia. Click here
Emperor Energy Ltd (ASX:EMP) has surged on delivering a 50% gas resource increase to 1.848 Tcf (trillion cubic feet) at its Vic/P47 Permit within the Judith Gas Field offshore Gippsland Basin in Victoria. Click here
GTI Resources Ltd (ASX:GTR) will pick up nearly 14,000 acres worth of contiguous ISR uranium exploration claims in Wyoming’s Great Divide Basin. Click here
Meeka Gold Ltd (ASX:MEK)...
EUROBIO SCIENTIFIC: MAINTAINING HIGH LEVEL RESULTS IN 2021
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
MAINTAINING HIGH LEVEL RESULTS IN 2021Total turnover of €184.7m
Growth in non-COVID activities (+14%)
Strong EBITDA at €78m
Increased cash generation at €66m (€55m in 2020)
Cash position at €102m and decrease in financial debt (€11m)
Acceleration of strategic deployment focused on proprietary products, international development, and new market segmentsParis, April 6, 2022 –7h30
Eurobio Scientific (FR0013240934, ALERS), a leading French group in specialty in vitro medical diagnostics, presents today its 2021 consolidated annual results, established according to French accounting standards and approved by the company’s board of directors which met on April 5, 2022.1.
In 2021, Eurobio Scientific maintained a high level of turnover and results, combining a strong activity related to the diagnosis of COVID in a context of strong reduction...
Caledonia Mining Corporation Plc: Appointment of Joint Broker
Written by Customer Service on . Posted in Public Companies.
ST HELIER, Jersey, April 06, 2022 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce the appointment of Liberum Capital Limited as its joint broker with immediate effect.
Enquiries:Caledonia Mining Corporation PlcMark LearmonthCamilla Horsfall
Tel: +44 1534 679 802Tel: +44 7817 841793
WH IrelandAdrian Hadden/ Jessica Cave/ Andrew De Andrade
Liberum Capital LimitedScott Mathieson/Kane Collings
Tel: +44 20 7220 1751
Tel: +44 20 3100 2000
BlytheRay Financial PRTim Blythe/Megan Ray
Tel: +44 207 138 3204
3PPBPatrick ChidleyPaul Durham
Tel: +1 917 991 7701Tel: +1 203 940 2538
Curate Public Relations (Zimbabwe)Debra Tatenda
Tel: +263 77280 2131
Corbion published agenda for AGM
Written by Customer Service on . Posted in Public Companies.
Corbion has published its agenda for the upcoming Annual General Meeting of Shareholders (AGM) to be held on 18 May 2022.
The full AGM agenda together with explanatory notes is available on Corbion’s website under Investor relations –> Shareholder information –> Shareholder meetings.AttachmentPress release AGM_agenda_ENG_2022
Addex Expands Pipeline with Selective M4 Positive Allosteric Modulator Program for the Treatment of Schizophrenia & Other Psychotic Disorders
Written by Customer Service on . Posted in Public Companies.
New Series of Potent and Selective Compounds Identified Using Proprietary Allosteric Modulator Screening Platform
Ad Hoc Announcement Pursuant to Art. 53 LR
Geneva, Switzerland, April 6, 2022 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it has moved a selective and potent M4 muscarinic receptor positive allosteric modulator (PAM) program into lead optimization. M4 PAMs have the potential to treat schizophrenia and other types of debilitating neuropsychiatric disorders.
“There is a strong and robust rationale for developing novel schizophrenia therapeutics by targeting allosteric sites of muscarinic receptor sub-types, particularly M4, based on growing scientific evidence,” noted Jean-Philippe...
TGS Announces a Second 3D Multi-Client Seismic Survey in the Egyptian Red Sea
Written by Customer Service on . Posted in Public Companies.
OSLO, Norway (28 February 2022) – TGS, a global provider of energy data and intelligence, today announced a new 3D seismic survey in the Red Sea, Egypt, in partnership with Schlumberger.
This survey represents the second phase of new acquisition for the partners in this region and will encompass a minimum of 5,000 square kilometers. Data will be acquired with long offsets and processed using a Pre-Stack Depth Migration (PSDM) workflow to enable subsalt imaging. The acquisition is expected to start in April 2022, with final products anticipated in mid-2023 to ensure availability ahead of future license rounds in the region.
Egypt’s attractive, stable investment climate, enhanced by established exploration infrastructure and complemented by regular, transparent, and well-managed licensing rounds, has helped bolster interest in...
Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)
Written by Customer Service on . Posted in Public Companies.
Extending existing master services agreement with Ares Genetics, to develop digital platform for development and life cycle management of antibiotics, to January 31, 2025Both parties strengthening focus on antibiotic stewardship and planning to engage in AMR surveillance and efforts to repurpose existing antibiotics.Collaboration focuses on next-generation sequencing (NGS) and AI-assisted bioinformatics solutions for surveillance and drug repurposing effortsBasel, April 6, 2022 — Sandoz today announces the extension and expansion until January 31, 2025 of its strategic collaboration agreement with Ares Genetics (Ares), aimed at driving cutting-edge digital solutions in the global fight against antimicrobial resistance (AMR).
The extension of the existing master services agreement with Ares, a subisidiary of OpGen Inc, reflects...
InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Another record year with continued industry leading growth and profitability supported by focused strategy and execution
Revenue growth expected to continue in the first quarter and throughout 2022
Strong balance sheet with $89 million cash supporting future profitable growth
NEW YORK and TORONTO and HERZLIYA, Israel, April 05, 2022 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) (“InterCure” or the “Company”) is pleased to announce its financial and operating results for the fourth quarter and year ended December 31, 2021. References herein to “preliminary results” refer to the preliminary results published by the Company on February 8, 2022. All amounts are expressed in New Israeli Shekels (NIS) or Canadian dollars ($), unless otherwise noted.
Fourth Quarter 2021 Key Financial...
Brookfield Renewable Announces Intention to Redeem its Series 11 Preferred Units
Written by Customer Service on . Posted in Public Companies.
BROOKFIELD, News, April 05, 2022 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) today announced that it intends to redeem all of its outstanding Class A Preferred Limited Partnership Units, Series 11 (the “Series 11 Preferred Units”) (TSX: BEP.PR.K) for cash on April 30, 2022. The redemption price for each Series 11 Preferred Unit will be C$25.00. Holders of Series 11 Preferred Units of record as of April 14, 2022 will receive the previously declared final quarterly distribution of C$0.3125 per Series 11 Preferred Unit.
Brookfield Renewable operates one of the world’s largest publicly traded, pure-play renewable power platforms. Our portfolio consists of hydroelectric, wind, solar and storage facilities in North America, South America, Europe and Asia, and totals approximately 21,000 megawatts of...